Tánaiste pays visit to Teva’s world-leading Ireland South East respiratory facility

The Tánaiste and Minister for Foreign Affairs and Trade Simon Coveney paid a visit to Teva Waterford recently. The Ireland South East site is focussed upon the research, development and production of next-generation products for the treatment of respiratory conditions. Teva’s Waterford facility, located in the Waterford Industrial Estate, has been in operation since 1985 and currently employs 610 people from the county and surrounding areas.

The facility is recognised as a global leader, not just in the Teva network but in the wider pharmaceutical industry, in the development of next generation respiratory products used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Today the facility manufactures and exports products with a net value of over €1 billion to markets across the globe.

The Tánaiste’s visit, overall, had a clear emphasis on acknowledging the significant achievements already realised by local pharma companies such as Teva in developing Ireland South East as an important cluster for pharmaceutical manufacturing in Ireland, whilst also exploring how these successes can be built upon.

Commenting on the visit, Julian Blair noted: “The visit by the Tánaiste and wider delegation acknowledges our track record as a pharmaceutical leader and significant employer in the region. However, even more importantly, the visit was an opportunity for Teva to reaffirm our commitment to Waterford and set out our plans for the future to the Tánaiste and wider Government which he represents. We are currently working to enhance and develop our facility for the future, with further developments expected in the period ahead.”